Board Members
| Board Member Name | Appointment Date | Term Expiration Date | Appointing Authority |
|---|---|---|---|
| Matt Balla, R.Ph., President | 08/02/2017 | 09/30/2027 | Governor |
| Mark Bunton, R.Ph., Vice President | 09/28/2020 | 09/30/2028 | Governor |
| Steven Anderson R.Ph. | 12/01/2003 | 09/30/2027 | Governor |
| Mark Smosna, R.Ph. | 03/01/52016 | 09/30/2027 | Governor |
| Jason Jablonski, R.Ph., | 09/29/2020 | 09/30/2028 | Governor |
| Andrew Meador, C.Ph.T. | 10/27/2023 | 09/30/2027 | Governor |
| Kate Snedeker, Consumer Member | 09/13/2023 | 09/30/2027 | Governor |
Pursuant to IC 25-1-6.5-2, members serve until a successor is appointed after the end of their term. Board members may serve multiple terms.
Calendar
Loading events
Indiana Board of Pharmacy Minutes & Agendas
NOTICE: Pursuant to the requirements of IC 5-14-1.5-2.9, recordings (archived copies) of the Indiana Board of Pharmacy’s public meetings are available here on the Indiana Professional Licensing Agency's (PLA's) YouTube Channel. Members of the public may submit public records requests online through the PLA’s APRA Portal, to potentially obtain recordings and/or records that are not currently available on the PLA’s YouTube Channel or here on the website, and are still within the State of Indiana’s retention schedules, the PLA’s retention schedules, or any other retention period afforded by law.
2026
- January 12, 2026
- February 9, 2026
- March 9, 2026
- April 13, 2026
- May 11, 2026
- June 8, 2026
- July 13, 2026
- August 10, 2026
- September 14, 2026
- October 5, 2026
- November 9, 2026
- December 14, 2026
2025
- January 13, 2025
- February 10, 2025
- March 10, 2025
- March 14, 2025 Rule Subcommittee
- March 28, 2025 Rule Subcommittee
- April 11, 2025 Rule Subcommittee
- April 14, 2025
- April 25, 2025 Rule Subcommittee
- April 28, 2025
- May 9, 2025 Rule Subcommittee
- May 12, 2025
- May 30, 2025 Rule Subcommittee
- June 6, 2025 Rule Subcommittee
- June 9, 2025
- June 20, 2025 Rule Subcommittee
- July 11, 2025 Rule Subcommittee - CANCELLED
- July 14, 2025
- July 18, 2025 Rule Subcommittee
- July 25, 2025 Rule Subcommittee
- August 1, 2025 Rule Subcommittee
- August 11, 2025
- August 22, 2025 Compounding Rule Subcommittee
- August 22, 2025 Rule Subcommittee Agenda
- August 29, 2025 Pharmacy Compounding Rule Subcommittee
- September 8, 2025
- October 6, 2025
- October 17, 2025 Rule Subcommittee Agenda
- October 24, 2025 Rule Subcommittee Agenda
- November 7, 2025 Compounding Rule Subcommittee
- November 10, 2025
- November 14, 2025 Rule Subcommittee
- November 21, 2025 Rule Subcommittee
- December 8, 2025
- December 12, 2025 Rule Subcommittee - CANCELED
2024
- January 8, 2024
- February 12, 2024
- March 11, 2024
- March 21, 2024
- April 10, 2024 Rulemaking Subcommittee
- April 15, 2024
- April 26, 2024 Rulemaking Subcommittee - CANCELLED
- May 3, 2024 Rulemaking Subcommittee
- May 13, 2024
- May 10, 2024 Rulemaking Subcommittee
- June 10, 2024
- June 18th, 2024 Rulemaking Subcommittee
- July 8, 2024
- August 9, 2024 Rulemaking Subcommittee
- August 12, 2024
- September 9, 2024
- September 30, 2024
- October 7, 2024
- November 15, 2024 Rulemaking Subcommittee
- November 18, 2024
- November 22, 2024 Rulemaking Subcommittee
- December 6, 2024 Rulemaking Subcommittee
- December 9, 2024
- December 13, 2024 Rulemaking Subcommittee
- December 20, 2024 Rulemaking Subcommittee
2023
2025
- January 13, 2025
- February 10, 2025
- March 10, 2025
- April 14, 2025
- April 28, 2025
- May 12, 2025
- June 9, 2025
- July 14, 2025
- August 11, 2025
- September 8, 2025
- October 6, 2025
- November 10, 2025
- December 8, 2025
2024
- January 8, 2024
- February 12, 2024
- March 11, 2024
- April 15, 2024
- May 13, 2024
- June 10, 2024
- July 8, 2024
- August 12, 2024
- September 9, 2024
- September 30, 2024
- October 7, 2024
- November 18, 2024
- December 9, 2024
2023
- January 9, 2023
- February 13, 2023
- March 13, 2023
- April 10, 2023
- May 15, 2023
- June 12, 2023
- July 10, 2023
- August 14, 2023
- September 11, 2023
- October 16, 2023
- November 13, 2023
- December 11, 2023
2022
- January 10, 2022
- February 14, 2022
- February 28, 2022
- March 14, 2022
- April 11, 2022
- May 9, 2022
- June 13, 2022
- July 11, 2022
- August 8, 2022
- September 12, 2022
- October 3, 2022
- November 14, 2022
- December 12, 2022
2021
- January 11, 2021
- February 8, 2021
- March 8, 2021
- April 12, 2021
- May 10, 2021
- June 14, 2021 - Executive Session Certificate
- June 14, 2021
- July 12, 2021
- August, 2021
- September 13, 2021
- October 8, 2021
- November 8, 2021
- December 13, 2021
2020
- January 13, 2020 - Executive Session Certificate
- January 13, 2020
- February 10, 2020
- March 9, 2020
- April 13, 2020
- May 11, 2020
- June 14, 2020
- July 13, 2020
- August 10, 2020
- August 28, 2020
- September 14, 2020
- October 5, 2020
- November 9, 2020
- December 14, 2020 - Executive Session Certificate
- December 14, 2020
2019
- January 14, 2019 - Executive Session Certificate
- January 14, 2019
- February 11, 2019
- March 11, 2019
- April 8, 2019
- May 13, 2019
- June 10, 2019
- July 8, 2019
- August 12, 2019
- September 9, 2019
- October 7, 2019
- November 4, 2019
- December 9, 2019
2018
- January 8, 2018
- February 12, 2018 - Executive Session Certificate
- February 12, 2018
- March 12, 2018
- April 9, 2018
- May 14, 2018
- June 11, 2018
- July 9, 2018
- August 13, 2018
- October 1, 2018
- November 5, 2018
- December 10, 2018
2017
License Types Granted by the Board
- Pharmacist
- Pharmacist Intern
- Pharmacy Technician
- Controlled Substance Registration
- CE Sponsor - Pharmacy
- Pharmacy
- Non-Resident Pharmacy
- Home Medical Equipment Service Providers
- Wholesale Drug Distributor
- Remote Dispensing Facility
- Third Party Logistics Provider
- Prescription Pad Provider
- Pharmacy Tech Training Program
Additional information may be found in Application Instructions.
Board Adopted Policy Statements
- Electronic Participation Policy
- DEA Manuals from the Department of Justice: Diversion Control Division | Publications & Manuals
Impaired Pharmacist Program
Pursuant to IC 25-26-13-4.5, the Indiana Board of Pharmacy has entered into an agreement with the Indiana Professionals Recovery Program (IPRP) to provide for the rehabilitation and monitoring of impaired pharmacists. The mission of this program is to offer pharmacists suffering from chemical dependency an option to administrative disciplinary action before the Indiana Board of Pharmacy. Participation in this program is voluntary; federal and state confidentiality laws apply to all participants.
Self referrals as well as family referrals are encouraged. Referrals by pharmacies or other employers can be made directly to IPRP. Any licensed pharmacist suffering from chemical dependency is eligible to enter the IPRN program.
The program offers services which include educational presentations to appropriate audiences, advice concerning actions related to chemically dependent pharmacists, intervention planning, assistance in conducting interventions, chemical dependency assessment, a monitoring contract, referrals to appropriate treatment programs, periodic personal and/or telephone contact with an assigned sponsor, random and for-cause urine drug screens, and written/verbal report of compliance of contract to appropriate individuals.
IPRP may be contacted by calling 219.707.8081 ext 1 or via email at info@inprp.org.